Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FibroBiologics, Inc. - Common Stock (NQ: FBLG ) 3.580 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 3.580 Bid (Size) 3.500 (5) Ask (Size) 3.650 (2) Prev. Close 3.580 Today's Range 3.580 - 3.580 52wk Range 1.078 - 55.00 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday October 30, 2024 Via Benzinga FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology October 29, 2024 From Fibrobiologics, Inc. Via GlobeNewswire Performance YTD -87.70% -87.70% 1 Month +29.24% +29.24% 3 Month -4.02% -4.02% 6 Month -62.55% -62.55% 1 Year -87.70% -87.70% More News Read More FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024 October 28, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases October 18, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office October 16, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit October 11, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa September 30, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Engages Southern Star Research as CRO in Australia September 19, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology September 12, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 06, 2024 From Fibrobiologics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session September 02, 2024 Via Benzinga FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology August 20, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Files 2024 Second Quarter Report August 07, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics to Present at JonesTrading Healthcare Summit 2024 July 15, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology June 25, 2024 From Fibrobiologics, Inc. Via GlobeNewswire FibroBiologics Set to Join Russell 2000® Index June 13, 2024 From Fibrobiologics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 11, 2024 Via Benzinga Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session June 07, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 06, 2024 Via Benzinga FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024 June 06, 2024 From Fibrobiologics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session June 05, 2024 Via Benzinga FibroBiologics Announces 2024 Annual Meeting of Stockholders May 15, 2024 From Fibrobiologics, Inc. Via GlobeNewswire Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session June 05, 2024 Via Benzinga FBLG Stock Earnings: FibroBiologics, Inc. – Common Stock Reported Results for Q1 2024 May 15, 2024 Via InvestorPlace FibroBiologics Files 2024 First Quarter Report May 14, 2024 From Fibrobiologics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
